DNB//Back Bay Announces Dates for the Nordic-American Healthcare Conference 2025
April 29 2024 - 12:00PM
Business Wire
The Leading US-Nordic Healthcare Public Equity
Investor Conference
DNB Markets (“DNB”) and Back Bay Life Science Advisors (“Back
Bay"), acting through the DNB//Back Bay Healthcare Partnership are
pleased to announce the dates for our highly anticipated 9th annual
Nordic-American Healthcare Conference (NAHC).
Hosted by DNB//Back Bay with Nasdaq Nordic, Innovation Norway
and Business Sweden, this pre-eminent US-based Nordic healthcare
equity investor event will convene in New York City on March 26–27,
2025, bringing together industry leaders, investors and innovators
from across the global healthcare sector.
Renowned for their excellence in life science development and
commercial leadership, the Nordic markets offer a wealth of
cutting-edge technologies that are shaping the future of global
healthcare. Showcasing this dynamism, NAHC 2025 will offer focused
tracks and panel discussions supported by DNB Markets’ recognized
research analysts exploring specific industry developments that
also reflect prominent capabilities in the Nordic region. NAHC 2025
will spotlight four key therapeutic and technology areas: rare
diseases, metabolic disorders, oncology and med-healthtech.
Approximately 30 carefully curated presenting companies,
predominantly mid- and large cap public companies along with select
pre-public private companies from the Nordics and the United
States, will take the stage to share their insights and strategies.
Over the course of two days, attendees will have the opportunity to
engage with these leading Nordic companies together with US
companies developing and commercializing adjacent and complementary
technologies.
Attendance at the conference is by invitation only through
DNB//Back Bay. Qualified investors and senior healthcare executives
are encouraged to request a seat for this exclusive event, which
will offer unparalleled networking opportunities along with panels
and presentations exploring meaningful insights into the latest
developments shaping the healthcare sector.
For more information and to request a seat at the
Nordic-American Healthcare Conference 2025, please visit
www.nordic-americanlifescience.com.
About the DNB//Back Bay Healthcare Partnership
DNB//Back Bay (“The Partnership”) provides healthcare companies
with strategic and M&A advisory services, licensing and
partnering support and execution services, a complete range of
corporate and investment banking products and services, and
full-scale origination and distribution capabilities in global
capital markets. Together, DNB and Back Bay Life Science Advisors
hold a unique position bridging the Nordic and US markets, offering
support to companies along the full continuum of life science and
healthcare. Learn more here: www.bblsa.com/dnb-back-bay-partnership
www.dnb.no/en/business/industry-expertise/healthcare/dnb-back-bay
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240429391516/en/
Jocelyn Serio Miller Back Bay Life Science Advisors
jmiller@bblsa.com 781-254-9273
Stål Ulvin Garberg DNB stal.ulvin.garberg@dnb.no +47 911 90
970